Website profiles · Technology insights · Alternatives

actimmune.com

Learn about ACTIMMUNE® (Interferon gamma-1b) for treating chronic granulomatous disease (CGD). See safety information.

No paid content found
Visit website
Profile views 2 Outbound visits 0 Normal
ACTIMMUNE® (Interferon gamma-1b) for CGD Full homepage screenshot

At a glance

Category
Education & Learning
Language
English
Paid-content signal
No paid content foundObserved
Registered
1997
Hosting
Amazon CloudFrontInferred
HTTPS certificate trusted
PassedObserved
Last updated

Website review

This review may include AI-generated content and is not individually verified. Domain, certificate and other facts come from the observed data on this page.

What is ACTIMMUNE used for?

ACTIMMUNE (interferon gamma-1b) is used to help people with chronic granulomatous disease (CGD) lower their risk of serious infection. On the product's site, "serious" is defined as an infection that requires hospitalization and/or intravenous (IV) antibiotics. The site states that ACTIMMUNE has been helping patients with CGD for over 30 years and points to clinical studies for its results.

Who this is for

CGD is an inherited condition in which certain immune cells don't kill bacteria and fungi effectively, so recurrent and sometimes severe infections are the main concern. ACTIMMUNE is used as part of an overall management plan for CGD — typically alongside standard anti-infective care prescribed by a specialist — rather than as a standalone cure.

What to expect from the site

  • Taking ACTIMMUNE: resources and tips for starting and staying on treatment.
  • Support and resources: a patient support program, upcoming events, and ways to connect with the CGD community.
  • CGD Specialist Finder: a tool to locate specialists in your area.

Practical next step

If you or a family member has CGD, ask your immunologist or CGD specialist whether interferon gamma-1b fits your regimen, what monitoring it requires, and how it combines with your current antibiotics or antifungals. For condition background and specialist care, the Immune Deficiency Foundation at Immune Deficiency Foundation and the NIH's genetic information resource at MedlinePlus are useful starting points.

A note on how to read the evidence

The site frames benefit in terms of reduced risk of serious infection, with a patient named Casey describing life with X-linked CGD. That is the site's own presentation; individual results vary, and the decision to use this therapy should rest on your clinician's assessment of your specific diagnosis and history rather than on any single testimonial.

How does ACTIMMUNE work to reduce infection risk in chronic granulomatous disease?

ACTIMMUNE (interferon gamma-1b) is used in chronic granulomatous disease (CGD) to lower the risk of serious infections. In CGD, phagocytes (neutrophils and macrophages) can engulf bacteria and fungi but cannot efficiently kill them, because the enzyme complex that produces the oxidative burst (NADPH oxidase) is defective. Interferon gamma is a natural signaling molecule that primes these cells; the medication provides additional interferon gamma-1b to enhance phagocyte function and the body's ability to fight infection. On the product site, the focus is on this risk-reduction benefit: it states that ACTIMMUNE has been helping patients with CGD lower their risk of serious infection for over 30 years, and defines a serious infection as one requiring hospitalization and/or intravenous antibiotics. It does not claim to cure CGD or replace antibiotics and antifungals.

What this means in practice

  • It is a preventive, immune-modulating therapy, not a treatment for an active infection.
  • It is used alongside standard prophylaxis and prompt infection management, not instead of them.
  • The goal is fewer and less severe infections over time, which can matter for school, work, travel, and long-term organ health.

A concrete scenario

A parent of a child with X-linked CGD might use the site's "Taking ACTIMMUNE" section to understand how to start and stay on therapy, and the "Support and resources" section to find the patient support program. The "CGD Specialist Finder" helps locate a specialist in their area. For background on CGD and inherited immune defects, the Immune Deficiency Foundation at Immune Deficiency Foundation is a practical next stop.

How to decide with a clinician

Ask your CGD specialist: what specific infection-prevention benefit is expected in your or your child's case, how ACTIMMUNE will be combined with antibacterial and antifungal prophylaxis, what side effects to watch for, and how adherence will be monitored. The most useful next step is to review the full prescribing information and safety information on the product site, then bring questions to your specialist.

What are the side effects and safety considerations of ACTIMMUNE?

ACTIMMUNE (interferon gamma-1b) is a prescription medicine used to reduce the frequency and severity of serious infections in people with chronic granulomatous disease (CGD). Because it is a biologic that modifies immune activity, side effects are common and some require prompt medical attention. The product's own site directs readers to its full safety information and prescribing information for the complete list; the points below summarize the categories of effects clinicians and patients typically watch for.

Common side effects

  • Flu-like symptoms: fever, chills, headache, muscle aches, and fatigue, especially after an injection
  • Injection-site reactions: redness, tenderness, or swelling where the drug is given
  • Nausea, vomiting, and diarrhea
  • Rash
  • Dizziness or generally feeling unwell

These effects are often most noticeable early in treatment and may lessen over time, but they can persist and may be dose-related.

Safety considerations to discuss with the care team

  • Blood counts: Interferon gamma-1b can lower white blood cell and platelet counts, so regular blood monitoring is typical.
  • Liver function: Liver enzyme changes have been reported; monitoring is part of routine care.
  • Heart and nervous system effects: In some patients, interferon gamma-1b has been associated with cardiac rhythm changes, chest pain, and neurologic symptoms such as confusion or gait problems. These need urgent evaluation.
  • Pre-existing conditions: People with a history of seizures, heart disease, or significant liver disease may need closer monitoring or a different risk-benefit discussion.
  • Pregnancy and breastfeeding: Use during pregnancy or while nursing should be decided with a clinician, weighing the benefit to the mother against potential risk to the infant.
  • Interactions: Other medications, including some that affect the bone marrow or liver, may compound effects; the care team should review the full medication list.

A practical next step

If you or a family member is starting or already taking ACTIMMUNE, keep a simple symptom log — date, injection time, temperature, and any new symptoms — and bring it to each visit. That record makes it easier for the clinician to distinguish expected flu-like reactions from something that needs a dose adjustment or further testing. The ACTIMMUNE site also offers a CGD Specialist Finder and patient support resources that can help connect you with clinicians experienced in managing these risks ACTIMMUNE® (Interferon gamma-1b) for CGD.

How is ACTIMMUNE administered and what is the typical dosing schedule?

ACTIMMUNE® (interferon gamma-1b) is given by subcutaneous injection — a shot into the fatty tissue just under the skin, typically in the thigh, upper arm, or abdomen. On the product's own site, the dosing conversation is framed under "Taking ACTIMMUNE," which points patients toward resources and tips for starting and staying on therapy rather than laying out a single universal schedule on the homepage. In practice, interferon gamma-1b for chronic granulomatous disease is usually injected three times per week, with the exact dose and timing set by the prescribing specialist based on body size, response, and tolerability.

What the injection routine typically involves

  • Route: Subcutaneous, using a small needle; the site is rotated to reduce irritation.
  • Frequency: Commonly three times weekly on non-consecutive days, though the specialist may adjust this.
  • Timing: Often evening dosing, since flu-like symptoms in the hours after injection are common and sleep can make them easier to manage.
  • Dose changes: A clinician may lower the dose or slow the ramp-up if side effects such as fever, chills, or fatigue are hard to tolerate.

A concrete scenario

A parent of a child with X-linked CGD might be taught to give the injection at home on, say, Monday, Wednesday, and Friday evenings. The child's specialist monitors growth, infection history, and side effects, then decides whether the current dose is right. This is where the site's "CGD Specialist Finder" and patient support program become practical: they help families locate experienced clinicians and get help with training, adherence, and logistics.

Decision criteria to keep in mind

Consideration Why it matters
Who administers it Self-injection or a caregiver is possible after training; a nurse can teach technique
Symptom pattern Pre-injection acetaminophen or adjusting timing may be discussed with the care team
Adherence support Missed doses reduce benefit; support programs and reminders help
Specialist input Dose and schedule are individualized, not fixed for everyone

For the specific dose and schedule that applies to you or your child, ask the prescribing immunologist or the support team connected through ACTIMMUNE® (Interferon gamma-1b) for CGD, and never change the regimen on your own.

What support programs and resources are available for patients starting ACTIMMUNE?

For patients starting ACTIMMUNE (interferon gamma-1b) for chronic granulomatous disease (CGD), the official site organizes help into three practical areas: treatment guidance, a patient support program with events, and a specialist finder.

What the site offers

  • Taking ACTIMMUNE: Resources and tips aimed at starting the therapy and staying on it consistently, which matters for a preventive treatment taken on an ongoing schedule.
  • Support and resources: A patient support program plus information on upcoming events, and a way to get connected to the CGD community.
  • CGD Specialist Finder: A search tool for locating specialists in your area based on your specific needs.
  • Community connection: A Facebook presence for hearing and sharing stories and tips from other patients and families, plus updates on new information and events.

How to use this in practice

If you or a family member is about to begin treatment, a sensible order is: ask your care team how the prescribed schedule fits your routine, then use the site's "Taking ACTIMMUNE" tips to build that routine, and use the Specialist Finder if you want a second opinion or need a clinician closer to home. The support program and community pages are most useful for the logistical and emotional side—managing refills, travel with medication, or simply hearing how others handle a long-term injectable therapy.

Deciding what fits

Need Where to start
Understanding how to start and stay on therapy Taking ACTIMMUNE resources
Day-to-day help, events, community Support and resources; Facebook community
Finding or changing a CGD specialist CGD Specialist Finder

One caveat: this site is sponsored by the manufacturer, Amgen, so treat its treatment framing as product information rather than neutral clinical advice, and confirm decisions with your own immunologist. For independent background on the condition, the Immune Deficiency Foundation at Immune Deficiency Foundation is a well-established patient organization, and clinical trial listings at ClinicalTrials.gov can show what research is underway.

How can I find a CGD specialist in my area?

Use the CGD Specialist Finder on ACTIMMUNE® (Interferon gamma-1b) for CGD as your starting point. It is designed to help patients locate specialists in their area for specific needs, so it is the most direct tool on this site for your question.

What to do next

  1. Open the CGD Specialist Finder and search by your location.
  2. Note two or three names rather than one, in case of wait times or referral requirements.
  3. Before booking, confirm the specialist's focus. CGD care often involves immunologists and hematologists, sometimes with infectious disease input, so ask whether the clinic regularly manages CGD.
  4. Check practical details: insurance acceptance, referral rules, travel distance and how urgent concerns are handled between visits.

What the site offers alongside the finder

The page also points to a patient support program, upcoming events and a community presence on Facebook. These can be useful for comparing notes with other families about which clinics they use and what to expect. Treat community posts as personal experience, not clinical guidance.

A quick way to choose

If you are newly diagnosed or changing care, prioritise a centre with CGD experience over simple proximity. If you are stable and mainly need routine monitoring, a closer clinic that coordinates with a CGD specialist may work well. For children, ask early about transition planning to adult care, since that handover is often where gaps appear.

If the finder returns nothing nearby, call your current doctor or a nearby immunology department and ask for a CGD referral; specialist centres frequently accept patients from outside their immediate region.

Related questions

More questions →
How Long Has ACTIMMUNE Been Used for CGD, and What Do the Clinical Studies Show?

ACTIMMUNE® (Interferon gamma-1b) has been used to help patients with chronic granulomatous disease (CGD) lower their risk of serious infection for more than 30 years, according to ACTIMMUNE.com. The site states this directly and points visitors to the ACTIMMUNE clinical studies for the supporting results, along with a separate section explaining how the medication works. If you are trying to verify the track record behind ACTIMMUNE rather than learn how to take it, those two areas of the site — the clinical studies and the mechanism explainer — are where the relevant content lives.

What the site says about how long ACTIMMUNE has been used

The homepage frames the duration as a headline claim: ACTIMMUNE "has been helping patients with chronic granulomatous disease (CGD) lower their risk of serious infection for over 30 years." Two things are worth separating in that sentence:

  • The population: patients with CGD.
  • The stated benefit: a lower risk of serious infection — not a cure, and not a claim about every type of infection.

The site defines "serious" in this context with a footnote: an infection is serious if you have to go to the hospital and/or get intravenous (IV) antibiotics. That definition matters because it sets the bar for what the "lower risk" claim is actually about.

What the clinical studies are said to show

ACTIMMUNE.com does not present study data on the homepage itself. Instead, it directs readers to "See the proven results in ACTIMMUNE clinical studies" — a link to a dedicated page. The homepage also offers a separate entry point to "See how ACTIMMUNE works."

So the honest answer to "what do the clinical studies show?" is: the site treats the study results as a distinct page rather than a summary claim, and the homepage's role is to state the 30-plus-year track record and route you to that detail. If you need the actual endpoints, patient numbers, or trial design, that is the page to open rather than the homepage.

How to check the evidence yourself

  1. Start at ACTIMMUNE.com and locate the clinical studies link referenced in the "YOUR LIFE IS WAITING" section.
  2. Read the study page for the specific outcomes measured — the homepage's own framing suggests the relevant outcome is serious infections as defined above.
  3. Use the "See how ACTIMMUNE works" link if you want the mechanism before or alongside the results.
  4. For questions about whether ACTIMMUNE is appropriate in a specific case, the site provides a CGD Specialist Finder to locate specialists in your area.

What the site does not tell you on its own

The homepage content does not include dosing, side effects, or eligibility criteria — those sit under "Taking ACTIMMUNE" and the safety information the site references. It also does not state pricing, insurance coverage, or whether any part of the site requires login; none of that appears in the available page content, so it should not be assumed either way.

Where patient support fits in

Beyond the clinical claims, the site offers a patient support program, upcoming events, and a CGD community connection through Facebook. There is also a note that following certain links takes you to a website sponsored by Amgen, with a continue/cancel prompt — worth knowing if you want to stay on the ACTIMMUNE.com domain.

For a patient or caregiver, the practical takeaway is this: the 30-year figure is a duration claim, the "lower risk of serious infection" is the benefit claim, and the clinical studies page is where the site expects you to verify the second one.

What Support and Resources Does ACTIMMUNE.com Offer for Patients Taking ACTIMMUNE?

ACTIMMUNE.com is the official website for ACTIMMUNE® (Interferon gamma-1b), a treatment used in chronic granulomatous disease (CGD). For patients already taking or about to start ACTIMMUNE, the site organizes its help into four areas: practical tips for starting and staying on treatment, a patient support program, events and community connections, and a CGD Specialist Finder tool. The site also states that ACTIMMUNE has been helping patients with CGD lower their risk of serious infection for over 30 years, and points to clinical studies for the supporting results.

Taking ACTIMMUNE: resources and tips

The "Taking ACTIMMUNE" section is aimed at both starting and continuing treatment. According to the site, it offers resources and tips for starting and staying on ACTIMMUNE. This is the section to check first if you or someone you care for has been prescribed the medication and you want practical guidance rather than general disease information.

The site frames the goal of treatment in patient terms: lowering the risk of serious infection. It defines a serious infection as one that requires a hospital visit and/or intravenous (IV) antibiotics. That definition is worth keeping in mind, because it is the outcome the clinical information on the site is measured against.

Patient support program

ACTIMMUNE.com describes a patient support program, presented under "Support and resources." The site indicates you can learn about the program, upcoming events, and more, and invites visitors to "get connected." If you are looking for ongoing help rather than a one-time read, this is the entry point the site provides.

The site does not spell out the specific services included in the program on the pages summarized here, so treat the program as something to explore and confirm directly rather than assume a particular set of benefits.

Events and community connection

Beyond the support program, the site lists upcoming events and offers a way to connect with the CGD community. It also links to Facebook, where you can hear and share stories and tips from others, stay up to date with new information, find out about upcoming events, and get involved. For patients and families who want peer experience alongside clinical guidance, this is the community-facing part of the site.

One patient perspective is featured on the site: Casey, who lives with X-linked CGD, appears in the "YOUR LIFE IS WAITING" section. The site uses this framing to emphasize life beyond the condition, with the message "Get out there."

CGD Specialist Finder

The site includes a CGD Specialist Finder tool. Its stated purpose is to help you locate specialists in your area for your specific needs. You start the search from the site, and results are intended to match you with specialists relevant to CGD.

Note that some links on ACTIMMUNE.com lead to external sites sponsored by Amgen. The site shows a notice before you leave, asking whether you want to continue to a website sponsored by Amgen, with "Continue" and "Cancel" options. If you prefer to stay within the original site, choose "Cancel."

How to use the site efficiently

If you want to… Go to…
Get tips for starting or staying on ACTIMMUNE Taking ACTIMMUNE
Learn about the patient support program Support and resources
Find events or connect with the CGD community Support and resources / Facebook link
Find a CGD specialist near you CGD Specialist Finder
Review the evidence behind the treatment Clinical studies referenced on the site

Because the site is the manufacturer's official resource, it is a reasonable starting point for treatment-related materials and support signposts. For medical decisions—including whether ACTIMMUNE is appropriate, how to manage side effects, or how to interpret study results for your situation—the site itself directs patients toward specialists, which is consistent with using the Specialist Finder as a complement to, not a replacement for, your care team.

What Is ACTIMMUNE.com?

ACTIMMUNE.com is the brand website for ACTIMMUNE® (Interferon gamma-1b), a prescription medicine used to help patients with chronic granulomatous disease (CGD) lower their risk of serious infection. The site is sponsored by Amgen and serves as an informational hub for patients, caregivers, and anyone researching the treatment — covering how the medicine works, what taking it involves, and where to find support and CGD specialists.

Who the site is for

The content is aimed primarily at people living with CGD and their families. The homepage features a patient story (Casey, who lives with X-linked CGD) and the tagline "Your life is waiting," framing the site around day-to-day life with the condition rather than purely clinical language.

If you are a clinician or researcher looking for full prescribing information, this site is a starting point, but it is oriented toward patient education and support rather than dense technical documentation.

What you'll find on the site

The main sections, based on the site's own navigation, are:

  • Taking ACTIMMUNE — resources and tips for starting and staying on the treatment.
  • Support and resources — a patient support program, upcoming events, and ways to get connected.
  • CGD Specialist Finder — a search tool to locate specialists in your area.
  • Clinical study results — the site states ACTIMMUNE has been helping CGD patients lower their risk of serious infection for over 30 years and points to clinical studies for the proven results.

The site also links out to social channels, including Facebook, for community stories and updates.

A note on how the site defines "serious"

The homepage includes a specific definition worth knowing: an infection is described as serious if you have to go to the hospital and/or get intravenous (IV) antibiotics. This framing matters because it is the outcome the treatment is presented as helping to reduce.

Sponsorship and external links

ACTIMMUNE.com is sponsored by Amgen. When you click certain links, the site shows a notice that you are leaving ACTIMMUNE.com and about to go to a website sponsored by Amgen, with options to continue or cancel. This is a standard disclosure pattern — it tells you when you are moving off the brand site to a related but separate destination.

What the site does not appear to cover

Based on the available page content, there are no pricing details, cost calculators, or payment platform links on the site. If you need information about cost, coverage, or financial assistance, you would need to look elsewhere or ask your care team directly.

Bottom line

ACTIMMUNE.com is an Amgen-sponsored brand site for ACTIMMUNE® (Interferon gamma-1b) in CGD. Use it to understand the treatment, find tips for starting and staying on it, connect with patient support and events, and locate a CGD specialist near you. For medical decisions, prescribing details, or cost questions, treat the site as one input and confirm specifics with your healthcare provider.

What Is ACTIMMUNE (Interferon gamma-1b) Used For in CGD?

ACTIMMUNE® (Interferon gamma-1b) is a prescription medicine used in patients with chronic granulomatous disease (CGD) to lower the risk of serious infection. On the product's website, a serious infection is defined as one that requires a hospital visit and/or intravenous (IV) antibiotics. The site states that ACTIMMUNE has been helping patients with CGD lower this risk for over 30 years and points to clinical studies for its proven results.

The core use: reducing serious infection risk in CGD

CGD is a condition in which the immune system struggles to fight certain bacterial and fungal infections. ACTIMMUNE's role, as described on actimmune.com, is not to cure CGD but to help reduce the chance that a patient develops an infection severe enough to need hospitalization or IV antibiotics.

The website frames this around real patient experience — for example, featuring Casey, who lives with X-linked CGD — and directs visitors to clinical study results for the supporting evidence.

What the site offers beyond the basic description

The actimmune.com homepage is organized around a few practical areas:

Section What it provides
Taking ACTIMMUNE Resources and tips for starting and staying on the medication
Support and resources A patient support program, upcoming events, and ways to connect
CGD Specialist Finder A search tool to locate specialists in your area
Community Facebook connection for stories, tips, and CGD community updates

These sections suggest the site is built for both new and current patients who want practical guidance, not just a definition of the drug.

Key points to keep in mind

  • It is a prescription medicine. The site presents ACTIMMUNE as a treatment for CGD, not a general immune booster.
  • The goal is risk reduction. The stated benefit is lowering the risk of serious infection — defined by the site as requiring hospital care and/or IV antibiotics.
  • Clinical studies are referenced. For specifics on how well it works and in whom, the site points to ACTIMMUNE clinical studies rather than summarizing outcomes on the homepage.
  • Support exists alongside the medication. The patient support program and specialist finder indicate that the site expects patients to need help navigating care, not just a prescription.

Where to go next

If you are researching ACTIMMUNE for yourself or someone with CGD, the site's "Taking ACTIMMUNE" and "Support and resources" sections are the most directly useful starting points. For questions about whether ACTIMMUNE is appropriate in a specific case, the CGD Specialist Finder can help locate a specialist — but any treatment decision should come from a qualified healthcare professional, since the website itself does not provide individualized medical advice.

How to Find a CGD Specialist or Connect With the CGD Community Through ACTIMMUNE.com

ACTIMMUNE.com offers two direct paths for this: a CGD Specialist Finder to locate specialists in your area, and a Support and resources section that connects you to a patient support program, upcoming events, and the CGD community on Facebook. Both are reachable from the site's main navigation. If you are looking for a doctor, start with the Specialist Finder; if you are looking for other patients and ongoing updates, start with the support and community links.

Finding a CGD Specialist

The site's CGD Specialist Finder is described as a way to "locate specialists in your area for your specific needs." The entry point is a Start search action.

What to expect when you use it:

  • Input: your location and, based on the site's wording, the type of need you are searching for.
  • Action: run the search from the Specialist Finder page.
  • Result: a list of specialists near you that you can review and contact.

A practical note: "in your area" searches depend on how you define your search radius. If your first search returns few or no results, widening the geographic range is the usual next step before concluding that no specialist is listed.

Connecting With the CGD Community and Support

The Support and resources section is where the site groups its patient-facing connections. According to the page, it covers:

  • A patient support program
  • Upcoming events
  • Other ways to get connected

Facebook community

The site invites visitors to follow on Facebook to "hear and share stories and tips from others." This is the most direct community channel described on the page — it is framed as a place for patient stories and practical tips, not just announcements.

Staying updated

The site also offers a way to stay up to date with new information, learn about upcoming events, and get involved with the CGD community. If you want event notices and new content without checking the site repeatedly, this is the channel to use.

What the Site Says About ACTIMMUNE Itself

Context matters when you are deciding who to contact. The site states that ACTIMMUNE® (Interferon gamma-1b) "has been helping patients with chronic granulomatous disease (CGD) lower their risk of serious infection for over 30 years," and points to ACTIMMUNE clinical studies for the proven results.

The page defines a serious infection as one where you have to go to the hospital and/or get intravenous (IV) antibiotics. It also includes a patient perspective — Casey, who lives with X-linked CGD — under a "Your life is waiting" theme.

Before You Use the Finder or Community Links

  • Specialist Finder: have your location ready, and be prepared to broaden your search area if the first attempt is too narrow.
  • Support program and events: these are reached through the Support and resources section rather than the Specialist Finder.
  • Facebook: following the page is the community step described on the site; it is separate from the specialist search.
  • Leaving the site: some links take you to an Amgen-sponsored website, and the site shows a confirmation prompt ("You are about to go to a website that is sponsored by Amgen") before continuing. Expect that extra step.

For medical questions about whether ACTIMMUNE is appropriate for a specific person, the site directs readers to its safety information and to a specialist — the Specialist Finder is the tool it provides for that second step.

Website Overview

An established domain and managed infrastructure suggest continuity of operations and may support dependable delivery, although neither guarantees service quality. Page metadata, canonical configuration and social previews work together to provide more consistent search and sharing presentation.

Domain and Registration

Registered in 1997, this domain has about 29 years of history. That suggests continuity, although ownership and purpose may have changed. The registrar, MarkMonitor Inc., specializes in corporate domain and brand management, suggesting attention to domain asset protection. Transfer-protection status is present, helping reduce the risk of unauthorized domain transfers. The domain uses the common .com extension, which is not an independent safety signal.

DNS and Email

The lowest TTL is 60 seconds, supporting rapid record changes at the cost of more frequent lookups. Nameservers are provided by Amazon Route 53, indicating managed DNS hosting. No MX record was found. A conventional explicit inbound-mail route is not configured. TXT records include verification markers for Google, Meta. Such markers may also remain after a service stops being used. DNSSEC signatures were not detected, so this additional DNS authenticity protection is not confirmed.

TLS and Certificates

The certificate includes the organization field Amgen Inc.. The certificate issuer is Sectigo Limited, a commercial certificate authority. The certificate uses an RSA 2048-bit public key, offering broad client compatibility. The server supplied a complete certificate chain. The certificate is valid for about 198 days in total, with 188 days remaining.

HTTP and Browser Security

The response lacks these common security headers: CSP, Permissions-Policy. No X-Powered-By header was found, reducing one common source of backend fingerprinting information. The x-cache, x-served-by, via response header indicates a CDN or caching proxy in the delivery path. No obvious internal addresses or debug information were found in the headers. Cookie security attributes are unknown.

Technology Stack Analysis

The public page identifies Google Tag Manager, Fastly, Amazon CloudFront without precise versions, leaving fewer clues for version-specific scanning.

Search and Social Sharing

Open Graph is partially configured; og:type is missing. Twitter Card metadata is configured. The title has 40 characters, within a common display range. A meta description is present, with 118 characters. The observed directives allow indexing and link following.

Hosting and Email

DNSAmazon Route 53
HostingAmazon CloudFront
EmailUnknown
Approximate IP geolocation (inferred; a CDN or proxy may differ from the origin server) United States flagUnited States Inferred 3.167.112.121

Registration details

RDAP / WHOIS

RegistrarMarkMonitor Inc.
Registered1997-03-20
Expires2027-03-21
Domain statusclient delete prohibited、client transfer prohibited、client update prohibited
Nameserversns-1330.awsdns-38.org、ns-1782.awsdns-30.co.uk、ns-212.awsdns-26.com、ns-795.awsdns-35.net
DNSSECunsigned

DNS records

DNS

TypeNameValueTTLPriority
Aactimmune.com3.167.112.12160—
Aactimmune.com3.167.112.12260—
Aactimmune.com3.167.112.2060—
Aactimmune.com3.167.112.6160—
NSactimmune.comns-1330.awsdns-38.org172800—
NSactimmune.comns-1782.awsdns-30.co.uk172800—
NSactimmune.comns-212.awsdns-26.com172800—
NSactimmune.comns-795.awsdns-35.net172800—
TXTactimmune.com7gj3ek6k8i1v23rs6fh927bjc61800—
TXTactimmune.com8upsrvi0gip4lvgn43r3g4sr311800—
TXTactimmune.comd30n4rb8dfmb0b.cloudfront.net1800—
TXTactimmune.comfacebook-domain-verification=ah8ywsl6zp8nlj3tb3aw4o5tt53njh1800—
TXTactimmune.comgoogle-site-verification=OyC-rWJ71fwvhGey29S7SOVI8mt26b0T3aJ3lJsyg7k1800—
TXTactimmune.comgoogle-site-verification=QY3qEzquDSuqr89RWD6IRJ4vKxOsnlOKhUC-te2SHV01800—
TXTactimmune.comgoogle-site-verification=qexS7QNbMrNKMdhZdqcDun_VSj4ei-12thY2ewiRvoY1800—
TXTactimmune.comjvfj5qf85k839n3mls61qoslrm1800—
TXTactimmune.comtinfoil-site-verification: a2e38f71431889e2c2e639267f9f68b6d1d8594c=00d6a07526310ad620442b379bf41709546e7cc21800—
TXTactimmune.comv=spf1 include:spf100.secureserver.net~all1800—
CNAMEwww.actimmune.comactimmune.com1800—

TLS and certificates

TLS / SSL

AssessmentNormal configuration
Supported protocolsTLSv1.2、TLSv1.3
Negotiated protocolTLSv1.3
Certificate subjectactimmune.com
IssuerSectigo Limited
Valid until2027-04-15T23:59 · Remaining when checked: 188 days
Verification detailsCertificate trust: Passed · Hostname match: Passed

HTTP response headers

HTTP

HeaderValue
content-typetext/html;charset=utf-8
cache-controlmax-age=300,s-maxage=300,stale-while-revalidate=3600
strict-transport-securitymax-age=31557600
x-frame-optionsSAMEORIGIN
x-content-type-optionsnosniff
referrer-policystrict-origin-when-cross-origin
set-cookieRedacted

Identified technologies

Google Tag ManagerFastlyAmazon CloudFront

Pages, Search and Sharing

Meta descriptionLearn about ACTIMMUNE® (Interferon gamma-1b) for treating chronic granulomatous disease (CGD). See safety information.
Canonical URLhttps://www.actimmune.com/
LanguageEnglish (default)
Twitter Cardsummary_large_image
All bots 0 allowed · 0 disallowed

User reviews (0)

  • No reviews yet.